Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05092295 · ClinicalTrials.gov registry record
Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury
A clinical trial of Brain Injuries, Traumatic, sponsored by Rebiscan.
- Active
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05092295: Active study of Brain Injuries, Traumatic, sponsored by Rebiscan.
NCT05092295 is a study of Brain Injuries, Traumatic that is active but no longer recruiting, run by Rebiscan. The registered enrollment target is 200 participants, below the 247-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05092295, a study of Brain Injuries, Traumatic, is active but no longer recruiting, sponsored by Rebiscan.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 100 TBI patients and 100 controls.
Primary Outcome
Patients who have diagnosed TBI and are admitted to the hospital for treatment will have their eyes scanned to identify whether the HITT device can accurately identify patients with TBI.
Conditions Studied
Interventions
- DEVICE Head and Intraocular Trauma Tool
- DIAGNOSTIC_TEST SCAT-5
Study Locations (1)
Virginia
- Carilion Roanoke Memorial Hospital - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT05092295 still lists
NCT05092295 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 247-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (19% lower).
The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Head and Intraocular Trauma Tool is the first listed.
NCT05092295 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05092295 about?
NCT05092295 is a clinical study titled "Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury". Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (...
What is the current status of trial NCT05092295?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2021-12-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05092295 study?
This clinical trial studies the following conditions: Brain Injuries, Traumatic.
What interventions are being tested in trial NCT05092295?
The interventions under investigation include: Head and Intraocular Trauma Tool (DEVICE), SCAT-5 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05092295?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05092295 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05092295's enrollment target sits among peer trials
200 9th of 21 higher than 10 of 21 other Brain Injuries, Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries, Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Morning Bright Light to Improve Sleep Quality in Veterans
RECRUITING · NA
-
mTBI Identification and Monitoring Through Retinal Scanning
RECRUITING
-
Automated Robotic TCD in Traumatic Brain Injury
RECRUITING
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Brain Oxygen Optimization in Severe TBI, Phase 3
RECRUITING · NA
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI